CHE: 2025 revenue grew 4.1% to $2.53B, but adjusted net income and EPS declined year-over-yearQuartr·8 hours agoCHE+1.63%
CHE: Strong VITAS results and share buybacks drove higher earnings and raised full-year guidanceQuartr·15 hours agoCHE+1.63%
Chemed Q2 FY26 GAAP diluted EPS climbs 43.7% to $5.13; revenue increases 8.8% to $673.3 millionPUBT·15 hours agoCHE+1.63%
Chemed Corporation $CHE Stock Position Cut by NewEdge Wealth LLCMarket Beat·1 day ago, 03:41 AMCHE+1.63%
Janney Montgomery Scott LLC Sells 3,618 Shares of Chemed Corporation $CHEMarket Beat·Jul 11 at 08:37 AMCHE+1.63%
Chemed Corporation (NYSE:CHE) Receives Consensus Recommendation of "Hold" from AnalystsMarket Beat·Jul 5 at 05:14 AMCHE+1.63%
Chemed updates financial calendar with second-quarter earnings release, conference callPUBT·Jul 1 at 08:02 AMCHE+1.63%
09:18 ETHospice Choices: VITAS® Healthcare Now Serves Manatee Countyprnewswire·Jun 16 at 08:19 AMCHE+1.63%